tirzepatide vision loss: GLP-1 drugs like Ozempic linked to 3 eye conditions Is Terzepatide Causing Blindness |

Most patients start at a lower dose that is increased over time based on response and tolerability

GLP-1-based therapies have earned FDA approval for obesity due to their remarkable weight loss effects

In the USA, national surveillance of emergency department visits and hospital admissions suggests a rate of 28 cases per 1000 adults with diabetes per year, with a worrisome increase in emergency department visits and admissions for DKA seen since 2009 [209]

Randomized controlled trials (RCTs) have shown that, compared to BI, GLP-1RA granted similar or greater HbA1c reductions, but with lower rates of hypoglycemia, substantial weight loss, and easier administration schedule [4]